Hints and tips:
...“Compliance has been rising in the list of priorities for MNCs, and that is all related to the new political climate under [president] Xi,” said Andrew Polk, the co-founder of business consultancy Trivium...
...Ireland-based Medtronic, for instance, was fined $17m by Chinese anti-monopoly authorities last year for price fixing in its multi-layered local distribution system....
...Merger and acquisition activity has also buoyed valuations, with $10bn-plus deals announced between Allergan and Actavis, Covidien and Medtronic, Hospira and Pfizer as well as CareFusion and Becton Dickinson...
...Elsewhere, Medtronic shares fell about 2 per cent to $58.06 after the medical device maker received an unfavourable ruling from a federal court in Delaware banning it from selling its aortic heart valve...
...Omar Ishrak CEO of Medtronic, US medical technology group, since June 2011. Took over as head of GE Healthcare in 2009. Joined GE in 1995, having worked at Philips. Jim McNerney CEO of Boeing....
...“Some are small, but it tends to be mostly big multinationals as they have larger numbers of stressed people,” says Arti Lal, a co-ordinator for the organisation....
...Medtronic, the largest US medical device maker by market value, fell 6.5 per cent to $31.76 after reporting disappointing profit and warning that its growth in 2010 would be below consensus estimates....
...Powell, CEO, General Mills 1115: Bill Hawkins, CEO, Medtronics 1140: Richard Edelman, President & CEO, Edelman 1205: Pascal Lamy, Director-General, World Trade Organization 1220: Shumeet Banerji, CEO, Booz...
...In 1998 Medtronic started a court case alleging Brainlab had infringed its patents....
...In earnings news, Medtronic, the medical device maker, reported solid gains in sales and earnings after the bell on Tuesday, but analysts were disappointed by revenue growth and shares were down 0.4 per...
...In earnings, Medtronic rose 4.3 per cent to $52.97 after its fourth-quarter earnings rose 10 per cent. Target said its quarterly results beat estimates and its shares were up 2.6 per cent at $59.54....
...Medical device maker Medtronic added 3.8 per cent to $48.92 – its best day in four months – after regulators in Australia approved the sale of its Endeavour heart stent, used to keep arteries open....
...Shares of medical device makers sank after Medtronic warned that revenue for the fiscal fourth quarter would fall short of its own forecasts due to a downturn in the US defibrillator market....
...Among medical companies expanding to Memphis are Medtronic Sofamor Danek, Johnson & Johnson, Baxter, Pfizer and Medline Industries....
...Medtronic fell 0.7 per cent to $48.94, while Boston Scientific shares fell 1.2 per cent to $34.10....
International Edition